Sep 6, 2021 | 2021, Investors, Press Releases
A virtual briefing for sell-side analysts is taking place at 12:00 ET / 17:00 BST / 18:00 CEST on September 29, 2021. Download pdf fileAug 27, 2021 | 2021, Press Releases, Scientific
We are pleased to announce that Philogen co-founder and CEO/CSO, Prof. Dario Neri is giving two lectures on September 1st, 2021: At the virtual International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) Prof. Neri is giving a presentation at 15:35 (CEST) with the...Aug 23, 2021 | 2021, Press Releases, Scientific
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer. Read MoreJul 2, 2021 | 2021, Press Releases, Scientific
Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered with AbbVie entered clinical studies Read moreJun 29, 2021 | Investors, Press Releases
Philogen S.p.A. rende noto che il verbale dell’Assemblea degli Azionisti tenutasi il giorno 31 maggio 2021, in sede ordinaria e straordinaria, è a disposizione del pubblico presso la sede legale della Società a Siena, Piazza La Lizza, 7, sul sito internet della...May 31, 2021 | Investors, Press Releases
L’Assemblea degli Azionisti di Philogen S.p.A. si è riunita in data 31/05/2021, in sede ordinaria e straordinaria. Download PDF document
Recent Comments